Asieris and Theramex sign Cevira Europe licensing deal
Asieris Pharmaceuticals and Theramex entered a licensing agreement for Cevira covering cervical precancer in Europe.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Asieris licenses CEVIRA to Theramex for Europe and other markets
Asieris Pharmaceuticals said it reached an exclusive licensing agreement with Theramex for CEVIRA in Europe, Australia, New Zealand and Turkey. The agreement is subject to conditions and covers commercialization rights outside Asieris' remaining territories.